Dongyuan Su

CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma

Jixing Zhao, Xiaoteng Cui, Zhan Qi et al. · Theranostics · 2024 · 39 citations · Full text

Medicine, Molecular Biology, Oncology +17

EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances the temozolomide efficacy via promoting ATF3 expression and inhibiting DNA damage repair in glioblastoma

Eryan Yang, Biao Hong, Yunfei Wang et al. · Cancer Letters · 2024 · 20 citations · Full text

Medicine, Molecular Biology, Oncology +17

EPIC-1042 as a potent PTRF/Cavin1–caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastoma

Biao Hong, Eryan Yang, Dongyuan Su et al. · Neuro-Oncology · 2023 · 18 citations · Full text

Medicine, Oncology, Pharmacology +17

Design, synthesis and biological evaluation of 4-aniline-thieno[2,3-d]pyrimidine derivatives as MNK1 inhibitors against renal cell carcinoma and nasopharyngeal carcinoma

Min Zhang, Li Jiang, Zhaoping Pan et al. · Bioorganic & Medicinal Chemistry · 2019 · 17 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Synthesis, antitumor activity and molecular mechanism of doxorubicin conjugated trimethyl-chitosan polymeric micelle loading Beclin1 siRNA for drug-resisted bladder cancer therapy

Zhou Zhong, Zhong Cheng, Dongyuan Su et al. · RSC Advances · 2018 · 11 citations · Full text

Medicine, Molecular Pharmaceutics, Pharmacology +15